[ad_1]
Mezzan Holding, one of the largest manufacturers and distributors of food and pharmaceuticals in the Gulf region, has announced the acquisition of 67% shares of Kuwait Saudi Pharmaceutical Company ("Seller" or "KSPICO" ), the only Kuwaiti pharmaceutical manufacturer. The company has a majority in the board of directors and the right of decision of the Kuwaiti company of the Saudi pharmaceutical industries, while allowing Mezzan to strengthen its presence and its products in the sector of the health, a sector of consumption vital and growing.
Mohammed Jbadim Al Wazzan, Executive Vice President of Mezzan Holding, said: "The KSA is one of the success stories of the Kuwaiti private sector. As a result of this acquisition, Mezzan's medical products sector will be a turning point: it will move from a retail sector to a manufacturing and distribution sector with diversified product lines and a customer base. regulated pharmaceutical industry in more than 11 countries.
Garrett Walsh, CEO of Mezzan Holding, said: "This acquisition is an important addition to the core of Mezzan's consumer services business, allowing it to expand and strengthen its presence in order to expand its business. increase its share of total national and regional consumption expenditure.
Source link
